Alpha Tau Medical Ltd. (DRTSW)
NCM
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Company overview
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company has a strategic collaboration agreement to develop and commercialize Alpha DaRT for the treatment of prostate cancer. The company is headquartered in Jerusalem, Israel.
Peers in industry
Alpha Tau Medical Ltd. has no peer companies in this window.
Recent press releases
April 2026
Alpha Tau launches two global trials for pancreatic cancer treatment
# 📄 What This Document Is This is a 6-K filing from Alpha Tau Medical, which is a report for the U.S. Securities and Exchange Commission (SEC) that foreign companies use to share important news. In this case, it's two major press releases about their pancreatic cancer treatment trials. It's not a r
March 2026
Alpha Tau Medical Ltd. — 6-K Filing
# 🧾 What This Document Is This is a **Form 6-K**, a report that foreign companies listed on U.S. exchanges (like Alpha Tau, based in Israel) file with the SEC to share material news with investors. This specific report contains a press release announcing a major milestone for their cancer therapy.
SEC filings
All filings →Insider trades
All insider trades →Alpha Tau Medical Ltd. has no reported insider trades in the last 90 days.
Institutional holders
All holders →People at Alpha Tau Medical Ltd.
All people →No officers or directors have been indexed for Alpha Tau Medical Ltd..